This study is completed in the United States, in Bulgaria, in Russia, .... It is testing Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Depression for depression in bipolarity.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 75 Years

Countries: United States, Bulgaria, Russia, ...
Sponsor: Intra-Cellular Therapies, Inc.
Condition: Bipolarity, Depression

View study

CompletedNCT04285515

study Evaluating Lumateperone Monotherapy in the Treatment of Depression in bipolarity or Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, BipolarityDrugFrom 18 Years to 75 Years

Countries: United States, Bulgaria, Russia, ...
Sponsor: Intra-Cellular Therapies, Inc.
Condition: Depression, Bipolarity

View study

TerminatedNCT03593213

Study Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in people with Schizophrenia

This study was terminated in the United States, in Bulgaria, in Malaysia, .... It focuses on schizophrenia.

In United States

SchizophreniaDrugFrom 18 Years to 64 Years

Countries: United States, Bulgaria, Malaysia, ...
Sponsor: AbbVie
Condition: Schizophrenia

View study

CompletedNCT02966873

study for Addiction and PTSD (PTSD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSD, AddictionDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: Medical University of South Carolina
Condition: PTSD, Addiction

View study

CompletedNCT04471207

study Intelligent Biometrics for PTSD - study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralFrom 18 Years to 75 Years

Countries: United States
Sponsor: Medical University of South Carolina
Condition: PTSD

View study

TerminatedNCT00109577

study of a Nutritional Supplement in Adults With Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugOver 18 Years

Countries: United States, Canada
Sponsor: University of Calgary
Condition: Bipolarity

View study

WithdrawnNCT05440721

study of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Click Therapeutics, Inc.
Condition: Addiction

View study

CompletedNCT02978599

study of AVL-3288 in Schizophrenia Patients

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Schizophrenia

View study

CompletedNCT02832037

study of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 50 Years

Countries: United States, Canada, United Kingdom, ...
Sponsor: Boehringer Ingelheim
Condition: Schizophrenia

View study

CompletedNCT02651584

study of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of people with Opioid Dependence

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Braeburn Pharmaceuticals
Condition: Addiction

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.